Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Inj. Insulin Aspart (Biosynthetic R Dna Origine) Penfill 100 Iu/Ml Cartridge
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106275358 |
|
Reference Number |
CH245152 |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | Allahabad |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/022024/106275358/viewNitPdf_4490436.pdf |
| Start Date | February 22, 2024 21:51 |
| End Date |
Expired
29/02/2024
Expired 956 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Inj. insulin aspart (biosynthetic r-dna origine) 100 iu / ml penfill
For complete deion and other details, please refer to tender
Read moreInj insulin aspart 100 iu/ml (monocomponent r-dna origin) 300 iu/ml catridges (novorapid penfill)
Read more
Inj insulin aspart 100 iu/ml (monocomponent r-dna origin) 300 iu/ml catridges (novorapid penfill)
Read more
Inj. biosynthetic r-dna origin mixture of soluble insulin aspart 50 percent protamine crystallised insulin aspart 50 percent ,100 iu/ml, 3 ml cartridge with complementary pen and ultrafine nano needle.
For complete deion and other details, please refer to tender
Read moreInj. biosynthetic r-dna origin mixture of soluble insulin aspart 50 percent protamine crystallised insulin aspart 50 percent ,100 iu/ml, 3 ml cartridge with complementary pen and ultrafine nano needle.
For complete deion and other details, please refer to tender
Read moreInj. biosynthetic r-dna origin mixture of soluble insulin aspart 50 percent protamine crystallised insulin aspart 50 percent ,100 iu/ml, 3 ml cartridge with complementary pen and ultrafine nano needle.
For complete deion and other details, please refer to tender
Read moreInj. biosynthetic r-dna origin mixture of 30 percent soluble insulin aspart (rys) and 70 percent protamine crystallised insulin aspart 100iu/ml, 3ml cartridge
For complete deion and other details, please refer to tender
Read moreGtl_medicine_(ph no.:10046) human insulin analogue inj (biosynthetic r-dna origin) soluble insulin aspart 100 iu/ml in 3.0 ml precision delivery device flexpens
For complete deion and other details, please refer to tender
Read moreof your Industry type